BridgeMD
New treatment option for Meniscus Tear
Official title Fibrine Clot-augmented Repair of Longitudinal Meniscus Tears
ClinicalTrials.gov ID: NCT06541756
What this study is testing
- What it's testing
- Longitudinal meniscal tears are a type of meniscal injury characterized by a displaced fragment of the meniscus that flips over into the joint, often resembling a buckle or handle. These tears typically occur in the medial meniscus and are often associated with traumatic knee injuries, particularly in athletes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- Presenting with a painful meniscus (lateral or medial) longitudinal tear
- Being between the ages of 18 and 50
- Not having undergone surgery on the same knee before
- Having an MRI taken at the end of the 1st year post-surgery
You likely can't join if
- Having additional collateral ligamentous damage along with the meniscus tear (such as MCL or LCL)
- Incomplete clinical scores at the end of the study
- A history of previous surgery on the same knee
- Having an active infection
- Not having a control MRI at the end of the 1st year
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.